Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-13

Clinical Trial Update: Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of raltitrexed-based transarterial chemoembolisation for metastatic colorectal cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raltitrexed (Raltitrexed)

Snippet

Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical | Conditions: Colorectal Cancer Metastatic | Phase 4 | Status: UNKNOWN